KIT Inhibition by Imatinib in Patients With Severe Refractory Asthma

New England Journal of Medicine - United States
doi 10.1056/nejmoa1613125
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Massachusetts Medical Society

Related search

Imatinib in Pulmonary Arterial Hypertension: C-Kit Inhibition

Pulmonary Circulation
PulmonaryRespiratory Medicine
2014English

Risk Factors for Frequent Asthma Exacerbation in Japanese Patients With Refractory Asthma

The Showa University Journal of Medical Sciences
2009English

KIT-Mutated Melanomas Respond to Imatinib

Cancer Discovery
Oncology
2013English

A Study of Patients With Severe Bronchial Asthma

The Journal of Kansai Medical University
1991English

Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?

European Clinical Respiratory Journal
2017English

Safety of Bronchial Thermoplasty in High Risk Patients With Severe Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients With Moderate to Severe Asthma

Journal of Allergy and Clinical Immunology: In Practice
AllergyImmunology
2018English

P204 Prevalence of Anxiety and Depression in Patients With Severe Asthma

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy